Spyre Therapeutics stockSYRE
Spyre Therapeutics trades at $96.59, 12.3% below its 52-week high (Aug 19, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +194.8% year to date, +322.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 4, 2027.
Ratings, candles, signals and the screener for SYRE — after you log in
Open the terminalFrequently asked questions about Spyre Therapeutics
What is the Spyre Therapeutics stock price?
At the close on Nov 5, 2026: $96.59 (−2.47% on the day). 52-week high: $110.17 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Spyre Therapeutics report earnings?
The next quarterly report is on Mar 4, 2027. Last quarter, earnings per share changed −527% year over year, revenue 0%.
Does Spyre Therapeutics pay dividends?
No, Spyre Therapeutics does not pay dividends.
Where does Spyre Therapeutics trade and how to buy it?
Ticker SYRE, exchange Nasdaq, listed since 2016. You can buy it through a broker with access to US exchanges.
Should I buy Spyre Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for SYRE are in the terminal after you log in.